Reducing Risk & Increasing Clearance Certainty through Insightful Regulatory Intelligence & Strategy for Supporting Innovative Study Design Teams to Secure Rapid Product Approval, Expand Indications and Maintain Compliance for Marketed Products
Regulatory executives throughout the life sciences industry are focused on securing rapid approval for new products, while at the same time expanding indications for existing products and maintaining compliance with ongoing regulations for marketed therapies, which requires the insight and implementation of regulatory intelligence and strategy on an ongoing basis. New regulatory policies, driven by authorities including the FDA and international health bodies are of great concern as executives look to rapidly interpret and realign policies and strategies in order to maintain compliance, with a focus on innovation in clinical study design, data integrity concerns and policies covering unique products such as biosimilars, combination products and breakthrough products which do not align with existing pathways.
From staying up-to-date on a continually changing regulatory landscape and providing feedback to influence policy changes, both within the US and globally, to providing insight to teams internally through a variety of methods such as webinars and forums, the demands of regulatory intelligence professionals in the life science industry are immense. With sessions focusing on benchmarking throughout the industry to decipher various interpretations and implementation of regulations to sessions highlighting innovative methods to educate internal teams, this meeting will provide an unrivaled opportunity for life science regulatory intelligence experts. Blending the highest level of perspectives from both industry veterans as well as regulatory and legal authorities, the Q1 Life Science Regulatory Intelligence & Strategy Conference will provide regulatory intelligence executives with the tools needed to leverage knowledge to impact product strategies and ensure compliance throughout the organization.
This program is eligible for up to 11.5 RAC credits. A certificate of attendance and final digital copy of the agenda will be provided to all attendees upon request. For further details regarding the submission process for RAC credits, please visit:https://www.q1productions.com/raps-credit/
Eric Jahnke | Sr. Marketing Manager | Q1 Productions
312.955.0424 | email@example.com